These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28397671)

  • 21. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S
    J Sex Med; 2010 Oct; 7(10):3449-59. PubMed ID: 20646181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of flibanserin "new female Viagra
    Terrier C; Terrier JE
    Prog Urol; 2016; 26(11-12):592-599. PubMed ID: 27663307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
    Stahl SM; Sommer B; Allers KA
    J Sex Med; 2011 Jan; 8(1):15-27. PubMed ID: 20840530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacodynamic effects of combined administration of flibanserin and alcohol.
    Stevens DM; Weems JM; Brown L; Barbour KA; Stahl SM
    J Clin Pharm Ther; 2017 Oct; 42(5):598-606. PubMed ID: 28608926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flibanserin.
    Vallejos X; Wu C
    J Pharm Pract; 2017 Apr; 30(2):256-260. PubMed ID: 26873507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Aalpona FTZ; Nagendra L; Selim S; Dutta D
    Medicine (Baltimore); 2024 Jun; 103(25):e38592. PubMed ID: 38905407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
    Thorp J; Palacios S; Symons J; Simon J; Barbour K
    BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
    [No Abstract]   [Full Text] [Related]  

  • 34. Flibanserin - the female Viagra?
    Shapiro D; Stevens D; Stahl SM
    Int J Psychiatry Clin Pract; 2017 Nov; 21(4):259-265. PubMed ID: 28434386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.
    Ferger B; Shimasaki M; Ceci A; Ittrich C; Allers KA; Sommer B
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):573-9. PubMed ID: 20422156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect Size in Efficacy Trials of Women With Decreased Sexual Desire.
    Pyke RE; Clayton AH
    Sex Med Rev; 2018 Jul; 6(3):358-366. PubMed ID: 29576442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
    Kingsberg SA; Althof SE
    J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flibanserin treatment increases appetitive sexual motivation in the female rat.
    Gelez H; Greggain-Mohr J; Pfaus JG; Allers KA; Giuliano F
    J Sex Med; 2013 May; 10(5):1231-9. PubMed ID: 23421417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.